Anna D. Kosinska

1.5k total citations
40 papers, 1.1k citations indexed

About

Anna D. Kosinska is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Anna D. Kosinska has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 22 papers in Hepatology and 20 papers in Immunology. Recurrent topics in Anna D. Kosinska's work include Hepatitis B Virus Studies (35 papers), Hepatitis C virus research (20 papers) and Immunotherapy and Immune Responses (19 papers). Anna D. Kosinska is often cited by papers focused on Hepatitis B Virus Studies (35 papers), Hepatitis C virus research (20 papers) and Immunotherapy and Immune Responses (19 papers). Anna D. Kosinska collaborates with scholars based in Germany, China and United States. Anna D. Kosinska's co-authors include Michael Roggendorf, Mengji Lu, Ulrike Protzer, Ejuan Zhang, Zhiyong Ma, Tanja Bauer, Jia Liu, Dieter Glebe, Pia L. Seiz and Dongliang Yang and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Anna D. Kosinska

39 papers receiving 1.1k citations

Peers

Countries citing papers authored by Anna D. Kosinska

Since Specialization

Citations

This map shows the geographic impact of Anna D. Kosinska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna D. Kosinska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna D. Kosinska more than expected).

Fields of papers citing papers by Anna D. Kosinska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna D. Kosinska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna D. Kosinska. The network helps show where Anna D. Kosinska may publish in the future.

Co-authorship network of co-authors of Anna D. Kosinska

This figure shows the co-authorship network connecting the top 25 collaborators of Anna D. Kosinska. A scholar is included among the top collaborators of Anna D. Kosinska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna D. Kosinska. Anna D. Kosinska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in mice 2024 ·Antiviral Research ·Thomas Michler, (unknown), (unknown), (unknown), Julia Festag, Anna D. Kosinska, Ulrike Protzer	2
2	CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Theresa Asen, (unknown), Wenshi Wang, (unknown), Anindita Chakraborty, (unknown), Christoph Kreer, Anna D. Kosinska, Sylvain Simon, Stephan Urban, Florian Klein, Stanley R. Riddell, Ulrike Protzer	4
3	Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component 2023 ·JHEP Reports ·Jinpeng Su, (unknown), Anna D. Kosinska, (unknown), (unknown), Pavlo Bielytskyi, (unknown), (unknown), (unknown), Katja Steiger, Ulrike Protzer, Anne K. Schütz	2
4	Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models 2023 ·Journal of Hepatology ·Jinpeng Su, Livia Brunner, (unknown), (unknown), (unknown), (unknown), Frank Thiele, Marian Wiegand, Carolin Mogler, Julio Aguilar, Percy A. Knolle, Nicolas Collin, Anna D. Kosinska, Ulrike Protzer	34
5	Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance 2022 ·JHEP Reports ·(unknown), Anna D. Kosinska, Kristina Kemter, (unknown), (unknown), (unknown), (unknown), Lisa Wolff, Jinpeng Su, Sandra Eßbauer, Gerd Sutter, Martin Scholz, Katrin Singethan, Jens Altrichter, Ulrike Protzer	5
6	Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B 2021 ·Frontiers in Immunology ·(unknown), (unknown), Anna D. Kosinska, Martin Pulé, Ulrike Protzer, Karin Wisskirchen	18
7	Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors 2021 ·Antiviral Research ·Chunkyu Ko, Jinpeng Su, Julia Festag, Romina Bester, Anna D. Kosinska, Ulrike Protzer	20
8	Fetomaternal immune cross talk modifies T-cell priming through sustained changes to DC function 2021 ·Journal of Allergy and Clinical Immunology ·(unknown), Sonakshi Bhattacharjee, (unknown), Fahd Alhamdan, (unknown), Andreas Muschaweckh, Daniel P. Potaczek, Anna D. Kosinska, Holger Garn, Ulrike Protzer, Harald Renz, Clarissa Prazeres da Costa	7
9	Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection 2019 ·Scientific Reports ·Anna D. Kosinska, (unknown), (unknown), Julia Festag, Jinpeng Su, Katja Steiger, Marie‐Louise Michel, Ulrike Protzer, Percy A. Knolle	26
10	Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice 2016 ·Vaccine ·Simone Backes, Clemens Jäger, Claudia J. Dembek, Anna D. Kosinska, Tanja Bauer, (unknown), Andris Dišlers, George Mutwiri, Dirk H. Busch, Lorne A. Babiuk, Georg Gasteiger, Ulrike Protzer	47
11	RNA Interference Mediated Suppression of HBV Transcripts Restores HBV-Specific Immunity and Enhances the Efficacy of Therapeutic Vaccination 2016 ·Journal of Hepatology ·Thomas Michler, Anna D. Kosinska, (unknown), (unknown), Daniela Grimm, Mathias Heikenwälder, Michael Roggendorf, Ulrike Protzer	2
12	Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the “magic bullet” to kill cccDNA 2015 ·Antiviral Research ·Ejuan Zhang, Anna D. Kosinska, Mengji Lu, Huimin Yan, Michael Roggendorf	28
13	The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection 2015 ·Cold Spring Harbor Perspectives in Medicine ·Michael Roggendorf, Anna D. Kosinska, Jia Liu, Mengji Lu	28
14	New therapeutic vaccination strategies for the treatment of chronic hepatitis B 2014 ·Virologica Sinica ·Jia Liu, Anna D. Kosinska, Mengji Lu, Michael Roggendorf	37
15	Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects 2014 ·Virology ·Ejuan Zhang, Anna D. Kosinska, Zhiyong Ma, Kirsten K. Dietze, Yang Xu, Zhongji Meng, Xiaoyong Zhang, Junzhong Wang, Baoju Wang, Ulf Dittmer, Michael Roggendorf, Dongliang Yang, Mengji Lu	14
16	Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96 2014 ·Archives of Virology ·(unknown), Anna D. Kosinska, Sima Rafati, Azam Bolhassani, Tahereh Taheri, Arash Memarnejadian, Seyed Moayed Alavian, Michael Roggendorf, (unknown)	17
17	Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck 2014 ·Medical Microbiology and Immunology ·Anna D. Kosinska, Jia Liu, Mengji Lu, Michael Roggendorf	29
18	Combination of DNA Prime – Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model 2013 ·PLoS Pathogens ·Anna D. Kosinska, Ejuan Zhang, (unknown), Jia Liu, Pia L. Seiz, Xiaoyong Zhang, Zhiyong Ma, Thekla Kemper, Melanie Fiedler, Dieter Glebe, Oliver Wildner, Ulf Dittmer, Mengji Lu, Michael Roggendorf	83
19	The Expression of PD-1 Ligands and Their Involvement in Regulation of T Cell Functions in Acute and Chronic Woodchuck Hepatitis Virus Infection 2011 ·PLoS ONE ·Ejuan Zhang, Xiaoyong Zhang, Jia Liu, Baoju Wang, Yongjun Tian, Anna D. Kosinska, Zhiyong Ma, Yang Xu, Ulf Dittmer, Michael Roggendorf, Dongliang Yang, Mengji Lu	36
20	Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein‐Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens 2008 ·Journal of Medical Virology ·Ilka Engelmann, D. Petzold, Anna D. Kosinska, Bouke G. Hepkema, Thomas F. Schulz, Albert Heim	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact